ETHYPHARM UK LIMITED
Get an alert when ETHYPHARM UK LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£2.7m
+1,105.9% highest in 3 filed years
Net assets
£14m
+7% highest in 3 filed years
Employees
95
+6.7% highest in 3 filed years
Profit before tax
£762k
+72% highest in 3 filed years
Net assets
3-year trend · vs Consumer Discretionary median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £10,829,000 | £14,973,000 | £23,764,000 | +58.7% | |
| Operating profit | £457,000 | £443,000 | £762,000 | +72% | |
| Profit before tax | £457,000 | £443,000 | £762,000 | +72% | |
| Net profit | £457,000 | £324,000 | £902,000 | +178.4% | |
| Cash | £76,000 | £222,000 | £2,677,000 | +1,105.9% | |
| Total assets less current liabilities | £12,498,000 | £12,822,000 | £13,724,000 | +7% | |
| Net assets | £12,498,000 | £12,822,000 | £13,724,000 | +7% | |
| Equity | £12,498,000 | £12,822,000 | £13,724,000 | +7% | |
| Average employees | 88 | 89 | 95 | +6.7% | |
| Wages | £5,566,000 | £6,361,000 | £6,516,000 | +2.4% | |
| Directors' remuneration | — | £106,000 | £172,000 | +62.3% | |
| Directors' pension contributions | — | £2,000 | £8,000 | +300% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | 4.2% | 3.0% | 3.2% | |
| Net margin | 4.2% | 2.2% | 3.8% | |
| Return on capital employed | 3.7% | 3.5% | 5.6% | |
| Gearing (liabilities / total assets) | 36.8% | 49.6% | 54.8% | |
| Current ratio | 2.72x | 2.02x | 1.83x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 2 times since incorporation
- ETHYPHARM UK LIMITED 2016-07-19 → present
- DB ASHBOURNE LIMITED 2014-01-17 → 2016-07-19
- DALLAS BURSTON PHARMA LIMITED 2013-06-11 → 2014-01-17
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Grant Thornton UK LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“To support the directors' assessment of the Company as a going concern, the Company undertakes regular forecasting of financial performance and cash flows. The approach to forecasting considers sensitivities around long term trading assumptions and the availability of funding and continued support from fellow Group entities. The directors have considered the financial position of the company at 31 December 2025 and the projected cash flows and financial performance of the company for the 12 months from the date of approval of these financial statements. The directors have also taken action to ensure that appropriate cash resources are available to fund the company's operations. Therefore, the directors consider, after making appropriate enquiries, that the Company has adequate resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the financial statements.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
5 active · 13 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| RUYANT, Foucauld | Secretary | 2024-09-30 | — | — |
| DE ULTRA DE SOUSA BARCELOS, Bruno | Director | 2023-01-17 | Aug 1973 | Portuguese |
| LASSERRE, Xavier Pierre Christian | Director | 2023-06-26 | Apr 1972 | French |
| MEHRAI, Alexander | Director | 2025-01-31 | Jun 1975 | British |
| RUYANT, Foucauld | Director | 2024-09-30 | Oct 1975 | French |
Show 13 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BURSTON, Sallyann | Secretary | 2013-06-11 | 2015-09-30 |
| BOVOLENTA, Andrea | Director | 2024-03-01 | 2024-06-05 |
| BURSTON, Dallas John, Dr | Director | 2013-06-11 | 2015-09-30 |
| CONCANNON, Paul Joseph | Director | 2019-03-12 | 2025-01-31 |
| DELUARD, Bertrand | Director | 2019-07-21 | 2022-09-13 |
| FARRANT, Andrew David | Director | 2015-09-30 | 2018-02-28 |
| JOANNESSE, Roseline Georgette | Director | 2018-03-30 | 2019-03-12 |
| LECAT, Jean-Hugues Louis Marie | Director | 2015-09-30 | 2019-07-21 |
| LIEPMANN, Susanne | Director | 2015-09-30 | 2018-03-30 |
| MONIN, Jean Bernard Claude | Director | 2022-11-01 | 2023-06-26 |
| PARRY, Philip Edward | Director | 2019-03-12 | 2022-12-31 |
| SCHMIDT, Emmanuel | Director | 2019-03-12 | 2022-12-31 |
| TOMKINS, Lisa Elaine | Director | 2018-02-28 | 2019-01-18 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Dallas Burston Ashbourne Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 79 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-08-21 | AA | accounts | Accounts with accounts type full | |
| 2025-10-28 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-09-22 | AA | accounts | Accounts with accounts type full | |
| 2025-01-31 | AP01 | officers | Appoint person director company with name date | |
| 2025-01-31 | TM01 | officers | Termination director company with name termination date | |
| 2024-12-12 | AA | accounts | Accounts with accounts type full | |
| 2024-10-30 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-10-17 | AP01 | officers | Appoint person director company with name date | |
| 2024-10-17 | AP03 | officers | Appoint person secretary company with name date | |
| 2024-10-17 | TM01 | officers | Termination director company with name termination date | |
| 2024-03-01 | AP01 | officers | Appoint person director company with name date | |
| 2023-10-30 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-10-03 | AA | accounts | Accounts with accounts type full | |
| 2023-07-10 | AP01 | officers | Appoint person director company with name date | |
| 2023-07-10 | TM01 | officers | Termination director company with name termination date | |
| 2023-05-10 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-01-27 | TM01 | officers | Termination director company with name termination date | |
| 2023-01-27 | AP01 | officers | Appoint person director company with name date | |
| 2023-01-27 | TM01 | officers | Termination director company with name termination date | |
| 2022-12-07 | AP01 | officers | Appoint person director company with name date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.